John Bramble: Ensuring Safe AI Integration in Medicine
John Bramble, Radiologist at Banner Health, shared a post on LinkedIn:
“There are customary steps in rolling out new treatment protocols.
Those protocols are reviewed by appropriate clinical committees (such as orthopedists reviewing venous thrombosis prevention protocols for patients undergoing joint replacement).
Documents are presented listing references to journal studies and professional society recommendations.
Discussions among physicians covering inclusion and exclusion criteria for application of the protocol needs to occur.
Just because you are using a large AI frontier model does not mean you should not complete the review of such protocols.
Oversight is mandatory.
If an AI model cannot provide the information necessary for oversight, it should not be used.
A real limitation of AI models is that they are not adequately trained on patients who are outliers, and outliers are far more common than most non clinicians think.
Ai applications in healthcare need significant oversight.
The amount of oversight needed may decrease in 5 -10 years after widespread use of an AI model, but there will always need to be some continuing oversight.
Both the healthcare organization and the AI model provider bear joint responsibility for oversight.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care